Gara Jalqabaatti › Leukemia Biphenotypicii Hamaa › Texas

Qorannoo klinikaalii Leukemia Biphenotypicii Hamaa Texas keessatti

Qorannoo 13 Leukemia Biphenotypicii Hamaa f Texas keessatti hirmaatuu jiru.

Magaalota Texas keessatti

Takkalaa qorannoo (Ingiliffa)

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

University of Texas MD Anderson Cancer Center, Houston

Namoota walitti qabaa jiraSadarkaa 1

Umuriin 12 hanga 78 · Saalaa hunda · Haaromfame 29-Ful-2026 · NCT03802695

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Dell Children's Medical Center of Central Texas, Austin
Driscoll Children's Hospital, Corpus Christi
Medical City Dallas Hospital, Dallas
fi 7 dabalataa

Namoota walitti qabaa jiraSadarkaa 2

365 Days · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06317662

Enasidenib and Azacitidine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia and IDH2 Gene Mutation

M D Anderson Cancer Center, Houston

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT03683433

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Dell Children's Medical Center of Central Texas, Austin
Driscoll Children's Hospital, Corpus Christi
Medical City Dallas Hospital, Dallas
fi 12 dabalataa

Namoota walitti qabaa jiraSadarkaa 3

365 Days – 25 Years · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT03959085

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Dell Children's Medical Center of Central Texas, Austin
Driscoll Children's Hospital, Corpus Christi
Medical City Dallas Hospital, Dallas
fi 10 dabalataa

Namoota walitti qabaa jiraSadarkaa 1/2

Hanga umuriin 22 · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT04726241

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

University of Texas MD Anderson Cancer Center, Houston

Namoota walitti qabaa jiraSadarkaa 1/2

Umuriin 13 hanga 90 · Saalaa hunda · Haaromfame 06-Hag-2026 · NCT06533579

Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

UT Southwestern/Simmons Cancer Center, Dallas
Cook Children's Medical Center, Fort Worth

Namoota walitti qabaa jiraSadarkaa 1

Umuriin 1 hanga 30 · Saalaa hunda · Haaromfame 03-Hag-2026 · NCT06177067

Personalized NK Cell Therapy in CBT

M D Anderson Cancer Center, Houston

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 15 hanga 80 · Saalaa hunda · Haaromfame 30-Ado-2026 · NCT02727803

A Study of Revumenib and Mezigdomide in People With Leukemia

MD Anderson Cancer Center (Data Collection Only), Houston

Namoota walitti qabaa jiraSadarkaa 1/2

Umuriin 12 fi ol · Saalaa hunda · Haaromfame 22-Wax-2026 · NCT07356154

Cladribine, Idarubicin, Cytarabine, and Quizartinib in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

M D Anderson Cancer Center, Houston

Namoota walitti qabaa jiraSadarkaa 1/2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 12-Wax-2026 · NCT04047641

Cladribine, Idarubicin, Cytarabine, and Venetoclax in Treating Patients With Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, or Blastic Phase Chronic Myeloid Leukemia

M D Anderson Cancer Center, Houston

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 20-Cam-2026 · NCT02115295

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

University of Texas(UT) Southwestern-Children's Medical Center, Dallas

Namoota walitti qabaa jiraSadarkaa 1/2

Umuriin 12 hanga 95 · Saalaa hunda · Haaromfame 15-Elb-2026 · NCT04329728

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

University of Texas, Southwestern, Dallas
Cook Children's Hospital, Fort Worth
Texas Children's Hospital/Baylor College of Medicine, Houston

Namoota walitti qabaa jiraSadarkaa 1

Umuriin 1 hanga 21 · Saalaa hunda · Haaromfame 06-Mud-2024 · NCT05476770

Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.